Drug-Drug Interactions in a Geriatric Outpatient Cohort: Prevalence and Relevance

By Tulner Linda R.  

Drugs & Aging, Vol. 25, Iss. 4, 2008-01 ,pp. : 343-355

Adis International

Access to resources Recommend Favorite

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

By Kostapanos Michael S.   Milionis Haralampos J.   Elisaf Moses S.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 11-28

Adis International

Access to resources Recommend Favorite

Are Circulating Metabolites Important in Pharmacokinetic Drug-Drug Interactions? A Retroanalysis of Clinical Data

By  

Current Drug Metabolism, Vol. 15, Iss. 8, 2014-01 ,pp. : 767-790

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Risk Management in Dutch Community Pharmacies: The Case of Drug-Drug Interactions

By Buurma Henk   De Smet Peter A.G.M   Egberts Antoine C.G.  

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite

Drug-Drug Interactions via Mechanism-Based Cytochrome P450 Inactivation: Points to Consider for Risk Assessment from In Vitro Data and Clinical Pharmacologic Evaluation

By  

Current Drug Metabolism, Vol. 8, Iss. 5, 2007-06 ,pp. : 449-462

Bentham Science Publishers

Access to resources Recommend Favorite